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Up to 50% of ischemic strokes in the young after thorough diagnostic work-up remain cryp-
togenic or associated with low-risk sources of cardioembolism such as patent foramen
ovale (PFO). We studied with cardiac magnetic resonance (CMR) imaging, whether left ven-
tricular (LV) non-compaction—a possible source for embolic stroke due to sluggish blood
flow in deep intertrabecular recesses—is associated with cryptogenic strokes in the young.
Methods
Searching for Explanations for Cryptogenic Stroke in the Young: Revealing the Etiology,
Triggers, and Outcome (SECRETO; NCT01934725) is an international prospective multi-
center case-control study of young adults (aged 18–49 years) presenting with an imaging-
positive first-ever ischemic stroke of undetermined etiology. In this pilot substudy, 30 cases
and 30 age- and sex-matched stroke-free controls were examined with CMR. Transcranial
Doppler (TCD) bubble test was performed to evaluate the presence and magnitude of right-
to-left shunt (RLS).
Results
There were no significant differences in LV volumes, masses or systolic function between
cases and controls; none of the participants had non-compaction cardiomyopathy. Semi-
automated assessment of LV non-compaction was highly reproducible. Non-compacted LV
mass (median 14.0 [interquartile range 12.6–16.0] g/m2 vs. 12.7 [10.4–16.6] g/m2, p =
0.045), the ratio of non-compacted to compacted LV mass (mean 25.6 ± 4.2% vs. 22.8 ±
6.0%, p = 0.015) and the percentage of non-compacted LV volume (mean 17.6 ± 2.9% vs.
15.7 ± 3.8%, p = 0.004) were higher in cases compared to controls. In a multivariate
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conditional logistic regression model including non-compacted LV volume, RLS and body
mass index, the percentage of non-compacted LV volume (odds ratio [OR] 1.55, 95% confi-
dence interval [CI] 1.10–2.18, p = 0.011) and the presence of RLS (OR 11.94, 95% CI 1.14–
124.94, p = 0.038) were independently associated with cryptogenic ischemic stroke.
Conclusions
LV non-compaction is associated with a heightened risk of cryptogenic ischemic stroke in
young adults, independent of concomitant RLS and in the absence of cardiomyopathy.
Clinical trial registration
SECRETO; NCT01934725. Registered 4th September 2013. https://clinicaltrials.gov/ct2/
show/NCT01934725
Introduction
There is growing evidence that the global incidence of ischemic stroke in young adults (18–50
years) has substantially increased since the 1980s [1]. Along with individual tragedy, early-
onset stroke accounts for a considerable socioeconomic impact due to long life expectancy of
these patients. Therefore, effective treatment and prevention strategies of strokes in the young
are of uttermost importance. However, up to 50% of ischemic strokes in young adults are cryp-
togenic, i.e. without evident causality or associated with low-risk cardioembolic sources after
standard diagnostic evaluation [2–4]. leading to untargeted secondary prevention. Further-
more, in these circumstances, the patient and proxies are left with uncertainty regarding the
nature and prognosis of such an event.
It has been suggested that most cryptogenic ischemic strokes are thromboembolic by
nature, having sources such as proximal arteries or heart, or venous sources via right-to-left
shunts [5]. The concept of embolic stroke of undetermined source (ESUS) was the first attempt
to systematically define this patient population, characterized by a non-lacunar brain infarct
without proximal occlusive arterial stenoses or major-risk cardioembolic source [6]. Patent
foramen ovale (PFO) is the most frequent low-risk cardiac finding in young patients with
cryptogenic ischemic stroke [2]. Based on most recent evidence, paradoxical embolism is the
likely cause for the stroke in many patients with PFO. However, a good proportion of these
PFOs may still represent a bystander without causal relation to the stroke and further research
on the mechanisms of PFO-related and PFO-nonrelated strokes are warranted [7]. Our pres-
ent study includes both ESUS (+) and ESUS (-) cryptogenic stroke patients.
We hypothesized that there would be subtle structural or functional cardiac abnormalities
detectable by cardiac magnetic resonance (CMR) imaging as possible novel sources for crypto-
genic strokes in the young beyond standard cardiac imaging work-up. Left ventricular (LV)
non-compaction (LVNC) has been suggested as a rare cause of embolic stroke due to sluggish
blood flow in deep intertrabecular recesses [8, 9]. CMR imaging has shown good reproducibil-
ity to estimate the global non-compacted LV mass [10–12]. In this pilot case-control study, we
studied whether non-compacted LV mass, the ratio of non-compacted to compacted LV mass,
and the percentage of non-compacted LV volume evaluated with CMR are associated with
cryptogenic ischemic stroke in the young.
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Searching for Explanations for Cryptogenic Stroke in the Young: Revealing the Etiology, Trig-
gers, and Outcome (SECRETO; NCT01934725) is an international prospective multicenter
case-control study of young adults (age 18–49) presenting with an imaging-positive first-ever
ischemic stroke of undetermined etiology. The main study protocol has been published in
more detail previously [13]. Briefly, patients are included after standardized and timely diag-
nostic procedures, including brain magnetic resonance imaging, imaging of intracranial and
extra-cranial vessels with either computed tomography angiography or magnetic resonance
angiography, and cardiac imaging to rule out established causes of ischemic stroke. The rou-
tine cardiac work-up included standardized transthoracic (TTE) and transesophageal echocar-
diography (TEE) with bubble test [14], transcranial Doppler (TCD) ultrasound with bubble
test, 12-lead ECG, and at least 24-hour Holter ECG. Those with PFO-related strokes were
included in the study. Patients were age- and sex-matched to stroke-free controls in a 1:1 fash-
ion. Controls were searched randomly through population registers. A list of 20 potential con-
trols per one patient were identified and invited with a letter one by one. In few cases, when
the aforementioned method was not successful, patients’ nonrelated proxies or proxies of the
study personnel served as controls. This study complies with the Declaration of Helsinki. Writ-
ten informed consent was obtained from all study participants. SECRETO has been approved
by the Ethics Committee of Helsinki and Uusimaa Hospital District.
In this single center substudy conducted in Helsinki University Hospital, 30 cases and 30
controls were examined with CMR and TCD bubble test with inclusion period between
December 2013 and May 2017. Consecutive patients enrolled in the main study, and control
subjects matched (for age ± 5 years and sex) to these patients, were asked to participate in the
study. Detailed clinical history was recorded from all study subjects, including actual blood
pressure, height and weight. Patients were classified as ESUS (+) and ESUS (-). Admission
National Institute of Health Stroke Scale (NIHSS) score were also recorded in patients as a
measure of stroke symptom severity. None of the patients had PFO closure before CMR.
CMR protocol
All subjects were imaged using a 1.5T Avantofit magnetic resonance imaging system (Siemens
Healthcare, Erlangen, Germany). A 32-channel body receiver coil was used in combination
with ECG-gating. Gated three-direction localizer was used as a basis for image acquisition.
Specific technical parameters for each sequence type used are reported in Supporting informa-
tion (S1 Table).
Half-Fourier-acquisition single-shot turbo spin echo (HASTE) sequence was first acquired
in transaxial planes covering the entire heart. The LV long axis was determined in this transax-
ial set of sections using the built-in three-point plane planning tool. The LV two-chamber
(2CH) view was defined with points in LV apex, and both caudal and cranial center of mitral
ring. Balanced steady-state free precession (bSSFP) cine images were then acquired, with carte-
sian sampling in 2CH view, followed by short-axis (SAX) cine images covering the entire
heart. Three-chamber (3CH), four-chamber (4CH) and right-ventricular outflow tract
(RVOT) views were acquired last before contrast agent administration.
Gadolinium-based contrast agent (gadoterate meglumine, Dotarem) of 0.2 mmol/kg was
used as a contrast agent. After contrast agent administration, through plane phase contrast
(PC) flow images were acquired for ascending aorta and pulmonary artery. Inversion time
(TI) scout was then acquired to probe the most suitable TI for phase-sensitive inversion
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recovery (PSIR). Ten to fifteen minutes after contrast administration late gadolinium enhance-
ment (LGE) images were acquired for the entire LV in SAX direction, and in 2CH, 3CH and
4CH directions.
CMR analysis
All images were analyzed by CMR-trained physicians (J.K., V.J., H.R., P.P.) blinded to case-con-
trol status and all clinical information. LV volumes and mass were evaluated using standard
protocols [15]. The presence of LGE was visually assessed and required the visibility in two
orthogonal planes. Image analysis was performed using QMass MR software1 (version 8.1,
Medis Medical Imaging Systems, Leiden, the Netherlands). Results are given as absolute values
and as indices standardized to body surface area (BSA) using the Mosteller formula [16].
Non-compacted and compacted LV masses were measured by a single observer (J.K.) using
a similar semi-automatic method as previously presented [10, 11]. Measurements were inde-
pendently repeated in twenty random subjects by another researcher (P.P.) to assess inter-
observer reproducibility. The whole semi-automatic quantification process of LVNC is pre-
sented in Fig 1. MassK mode of Qmass software was used to automatically segment blood and
muscle tissue based on pixel intensities, with the nominal threshold of the algorithm. Basal
slice or slices containing both LV and mitral valve were excluded to avoid incorrect detection
of mitral valve structures as trabeculated myocardium. Thus, we accepted the resulted under-
estimation of LV mass and volume for this analysis. Papillary muscles were included in com-
pacted LV mass and excluded from end-diastolic LV volume. In addition to non-compacted
LV mass, we determined the ratio of non-compacted to compacted LV mass and the percent-
age of non-compacted LV volume of end-diastolic LV volume.
Transcranial Doppler bubble test
Status of right-to-left shunt (RLS) was evaluated with TCD bubble test in both cases and con-
trols. TCD was performed according to consensus guidelines in unilateral insonation of
Fig 1. Quantification of left ventricular (LV) non-compacted mass. a) QMass software was used to define LV epicardial (green line) and endocardial (red
line) borders. These borders were manually adjusted after automatic quantification. b) Papillae were manually quantified (pink and orange lines). c) MassK
mode activated: the algorithm applies to areas inside the epicardial borders, and defines myocardium (green color) according to pixel intensities automatically
according to the set threshold. Non-compacted LV mass was achieved by subtracting compacted LV mass from the total LV mass (green color). Compacted LV
mass included both LV wall (areas between green and red lines) and papillary muscles (areas within pink and red lines). These analyses were made for all short
axis cine end-diastolic slices that contained LV except the most basal slices.
https://doi.org/10.1371/journal.pone.0237228.g001
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middle cerebral artery in semisupine position [17]. Agitated 10 mL saline-blood solution was
injected into the right antecubital vein. The test was performed at rest and with at least once
with well-performed Valsalva maneuver. The presence of RLS (�3 microbubbles) and highest
degree of RLS were recorded. Moderate-to-severe RLS (�10 microbubbles), was considered
clinically significant, consistent with recent consensus statement [7].
Statistical analysis
Normality of continuous variables was tested using the Shapiro-Wilk test. Continuous vari-
ables are presented as mean ± standard deviation for normally distributed variables or median
(interquartile range) for non-normally distributed variables, and categorical variables as fre-
quency (%).
In case-control analyses, comparison between paired dichotomous variables was performed
with McNemar’s test, between normally distributed continuous variables with repeated mea-
sures Student’s t-test, and between non-normally distributed continuous variables with Wil-
coxon signed rank test. Conditional logistic regression allowed assessing the association of
non-compacted LV volume with stroke adjusting for the presence of RLS and body mass index
(predefined model). Since moderate-to-severe RLS was not eligible for conditional logistic
regression, comparison between patients with and without moderate-to-severe RLS was per-
formed with independent samples t-test.
To study inter-observer reproducibility, Bland-Altman analysis [18] was performed and
intraclass correlation coefficients calculated by using a two-way mixed model for consistency.
A p-value of<0.05 was considered statistically significant and all tests were 2-sided. Statistical
analysis was performed on SPSS 25 statistical package (SPSS, Chicago, IL).
Results
Clinical characteristics
The median age of cases at stroke onset was 41 (35–44) years and of stroke-free controls at
study inclusion 42 (35–45) years (p = 0.131). Half of both cases and controls were women.
Patients were taller, they had higher body weight, and larger BSA. There were no significant
differences in cardiovascular risk factors between the groups (Table 1). Neither cases nor con-
trols had previous known cardiovascular diseases, such as coronary artery disease, atrial fibril-
lation, heart failure, or peripheral artery disease. At least moderate RLS was more frequent in
cases compared to controls (40% vs. 3%, p = 0.001). The median NIHSS score of cases was 1.5
(0–4) and 70% of cases fulfilled the ESUS criteria.
Basic structures and function
The mean duration from stroke to CMR was 31 ± 12 months (median 28, interquartile range
22–41, range 14–52). There were no significant differences in LV volumes, masses or stroke
volumes between cases and controls (Table 2). Also, aortic and pulmonary artery stroke vol-
umes obtained by PC flow measurements were similar between the groups. Four of 30 cases
had atrial septal aneurysm compared to none of the controls (p = 0.125). Pulmonary vein sta-
tus was similar between groups. All study subjects had visually normal LV shape, morphology
and trabeculation, and only one case had visible LGE (p = 1.000).
Left ventricular non-compaction
Non-compacted and compacted LV masses were measured with a high degree of inter-
observer reproducibility (Table 3).
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Non-compacted LV mass was greater in patients than in controls (median 14.0 [12.6–16.0]
g/m2 vs. 12.7 [10.4–16.6] g/m2, p = 0.045) (Table 4). We also observed both a higher ratio of
non-compacted to compacted LV mass (25.6 ± 4.2% vs. 22.8 ± 6.0%, p = 0.015) and a higher
Table 1. Baseline characteristics of young adults with cryptogenic stroke and stroke-free controls.
Cases (n = 30) Controls (n = 30) P-value
Demographics and body measurements
Age at stroke onset or at inclusion, years 41 (35–44) 42 (35–45) 0.131
Gender, female 15 (50) 15 (50) 1.000
Height, cm 175 ± 9 171 ± 9 0.013
Weight, kg 87 ± 18 79 ± 17 0.042
Body surface area, m2 2.04 ± 0.24 1.93 ± 0.24 0.022
Body mass index, kg/m2 28.4 ± 5.0 26.9 ± 5.2 0.294
Cardiovascular risk factors
Hypertension� 9 (30) 4 (13) 0.227
Diabetes type 1 1 (3.3) 0 (0) 1.000
Any diabetes 1 (3.3) 0 (0) 1.000
Current smoking 9 (30) 11 (36.7) 0.774
Alcohol week doses† 2 (1–4) 4 (2–6) 0.416
Physical inactivity 4 (13) 4 (13) 1.000
Right-to-left shunt†† 19 (63.3) 12 (40.0) 0.065
Right-to-left shunt, at least moderate†† 12 (40.0) 1 (3.3) 0.001
Stroke characteristics
Fulfills ESUS criteria 21 (70.0) NA
NIH Stroke Scale 1.5 (0–4) NA
Values are mean ± standard deviation, median (interquartile range) or number (%)
�Hypertension on any criteria (office hypertension > 150/90, history of hypertension, or blood pressure medication prior stroke)
†One control had missing data.
††Evaluated with transcranial Doppler (n = 59) and transesophageal echocardiography (n = 1)
ESUS, Embolic Stroke of Undetermined Source; NA, not applicable; NIH Stroke Scale—National Institute of Health Stroke Scale.
https://doi.org/10.1371/journal.pone.0237228.t001
Table 2. Cardiac magnetic resonance of young adults with cryptogenic stroke and stroke-free controls: Basic structures and function.
Cases (n = 30) Controls (n = 30) P-value
LV end-diastolic volume index, ml/m2 82.5 (77.9–89.3) 84.5 (76.0–93.5) 0.910
LV end-systolic volume index, ml/m2 30.5 ± 6.0 31.1 ± 7.2 0.734
LV stroke volume index, ml/m2 54.0 ± 7.0 55.0 ± 10.3 0.666
LVEF, % 64.1 ± 4.7 63.8 ± 5.1 0.820
LA volume max index, ml/m2 44.5 ± 6.7 44.7 ± 8.3 0.907
Aortic stroke volume�, ml 99.0 ± 16.2 97.5 ± 17.9 0.730
Pulmonary artery stroke volume�, ml 93.7 (83.4–106.3) 93.5 (87.6–106.2) 0.863
Atrial septal aneurysm 4 (13.3) 0 (0.0) 0.125
Pulmonary vein status abnormality† 6 (20.0) 5 (16.7) 1.000
Values are mean ± standard deviation, median (interquartile range) or number (%)
�Only 29 cases had flow measurements (results of 29 case-control pairs)
† Normal pulmonary veins defined as four separate returning veins to left atrium.
LA, left atrial; LV, left ventricular; LVEF, left ventricular ejection fraction.
https://doi.org/10.1371/journal.pone.0237228.t002
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percentage of non-compacted LV volume (17.6 ± 2.9% vs. 15.7 ± 3.8%, p = 0.004) in cases
compared to controls.
In a predefined multivariate conditional logistic regression model including non-com-
pacted LV volume, the presence of RLS and body mass index, non-compacted LV volume
(odds ratio [OR] 1.55, 95% confidence interval [CI] 1.10–2.18, p = 0.011) and RLS (OR 11.94,
95% CI 1.14–124.94, p = 0.038) were independently associated with cryptogenic ischemic
stroke (Table 5).
There were no significant differences in LVNC parameters between patients with or with-
out at least moderate RLS (Table 6).
Discussion
To the best of our knowledge, this is the first prospective case-control study to demonstrate an
association between LVNC and cryptogenic ischemic stroke in young adults. The main finding
of this study was that the percentage of non-compacted LV volume was higher in young adults
with cryptogenic ischemic stroke compared to stroke-free controls of similar age and gender,
independently of the presence of RLS. Moreover, non-compacted LV mass and the ratio of
non-compacted to compacted LV mass were higher in patients compared to controls (Fig 2).
Heart failure, arrhythmias and systemic thromboembolic events are major clinical manifes-
tations in LVNC [19–21]. As such, the LVNC can be caused by a genetic disorder of the myo-
cardium, pathological loading conditions or physiological adaptation of the LV [22, 23]. The
prevalence of LVNC has been highly variable, depending on the used imaging modality, study
cohort and diagnostic criteria [24]. It has been controversial whether LVNC is an independent
risk factor for stroke, or if embolism occurs mainly with atrial fibrillation or systolic dysfunc-
tion, both frequently associated with LVNC. In a retrospective case-control study of 62 patients
Table 3. Inter-observer reproducibility of non-compaction measurements in 20 subjects.
Observer 1 Mean (SD) Observer 2 Mean (SD) Blandt-Altman Mean (SD) ICC (95% CI) P-value
Non-compacted LV mass, g/m2 14.1 ± 3.9 14.4 ± 4.3 -0.3 ± 1.5 0.937 (0.847–0.974) <0.001
Compacted LV mass, g/m2 59.0 ± 14.2 58.7 ± 13.0 0.3 ± 2.8 0.988 (0.970–0.995) <0.001
Non-compacted to compacted LV mass ratio, % 24.1 ± 5.0 24.6 ± 5.1 -0.5 ± 2.9 0.833 (0.626–0.930) <0.001
Non-compacted LV volume, % of EDV 16.4 ± 2.5 16.6 ± 3.1 -0.3 ± 1.4 0.883 (0.729–0.952) <0.001
Values are mean ± standard deviation
CI, confidence interval; EDV, end-diastolic volume; LV, left ventricular end-diastolic volume; ICC, intraclass correlation coefficient; SD, standard deviation.
https://doi.org/10.1371/journal.pone.0237228.t003
Table 4. Cardiac magnetic resonance of young adults with cryptogenic stroke and stroke-free controls: Left ven-
tricular non-compaction analysis.
Cases (n = 30) Controls (n = 30) P-value
Non-compacted LV mass, g 30.0 ± 7.4 26.4 ± 10.1 0.014
Non-compacted LV mass index, g/m2 14.0 (12.6–16.0) 12.7 (10.4–16.6) 0.045
Compacted LV mass, g 116.1 (95.7–135.8) 110.0 (93.4–127.7) 0.229
Compacted LV mass index, g/m2 55.3 (50.7–65.2) 57.1 (52.8–63.7) 0.797
Non-compacted to compacted LV mass ratio, % 25.6 ± 4.2 22.8 ± 6.0 0.015
Non-compacted LV volume, % of EDV 17.6 ± 2.9 15.7 ± 3.8 0.004
Values are mean ± standard deviation or median (interquartile range).
Papillary muscles are included in compacted LV mass.
EDV, end-diastolic volume; LV, left ventricular.
https://doi.org/10.1371/journal.pone.0237228.t004
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with LVNC and 62 controls matched with age, gender and systolic function, LVNC itself was
not associated with stroke or embolism [25]. In that study, LVNC was detected by echocardi-
ography, which is less sensitive compared to CMR, and the selection process of the controls
was unclear. In two other retrospective analyses, it was concluded that stroke is a rare compli-
cation of LVNC without other risk factors [8, 9]. In a recent meta-analysis, the risk of throm-
boembolism in patients with LVNC was similar to patients with dilated cardiomyopathy [26].
In our study, we observed an association between increased trabeculated myocardial tissue
and cryptogenic ischemic stroke in young adults. The median non-compacted LV mass was
1.3 g/m2 higher, the mean non-compacted to compacted LV mass ratio 2.8% higher, and the
percentage of trabeculated LV volume 1.9% higher in patients compared to stroke-free con-
trols. Although these changes are relatively small, altogether 70% of our cases fulfilled the
ESUS criteria and it has been presented that patients with ESUS have on average minor strokes
consistent with small emboli [25].
Altogether 40% of our patients had at least moderate RLS, consistently with previous
knowledge that PFO is a frequent low-risk cardiac finding in young adults with cryptogenic
stroke [2]. However, a good proportion of PFOs may still represent a bystander [7]. In our
study, 5% increase in non-compacted LV volume resulted in 9-fold risk (OR) of cryptogenic
stroke, adjusted for the presence of RLS. Thus, the association between LVNC and cryptogenic
stroke seemed to be independent of RLS, strengthening the hypothesis that there are also other
RLS-nonrelated cardiac functional and structural factors increasing the likelihood for crypto-
genic stroke in the young.
Assessment of the global trabecular LV mass has shown good reproducibility in previous
studies [10–12]. Both our patients and controls had similar non-compacted LV masses com-
pared to healthy subjects in an earlier study [27]. but higher compared to two other studies
[10, 11]. The probable explanation for this difference is that our semi-automated method
included more inter-trabecular space to non-compacted mass, as CMR does not differentiate
Table 5. Conditional logistic regression: Risk factors for cryptogenic ischemic stroke in young adults.
Univariate Multivariate�
OR 95% CI P-value OR 95% CI P-value
Right-to-left shunt, Yes/No 4.50 0.97–20.83 0.054 11.94 1.14–124.94 0.038
Non-compacted LV volume, % of EDV 1.39 1.07–1.79 0.013 1.55 1.10–2.18 0.011
Body mass index, kg/m2 1.06 0.95–1.17 0.299 0.965 0.845–1.103 0.602
Values are mean ± standard deviation
�Predefined model.
CI, confidence interval; EDV, end-diastolic volume; LV, left ventricular end-diastolic volume; OR, odds ratio.
https://doi.org/10.1371/journal.pone.0237228.t005
Table 6. Left ventricular non-compaction in patients (n = 30) with and without moderate-to-severe right-to-left
shunt (RLS).
RLS- (n = 18) RLS+(n = 12) P-value
Non-compacted mass, g/m2 14.1 ± 2.2 15.3 ± 3.4 0.260
Compacted LV mass, g/m2 57.9 ± 9.6 57.2 ±9.3 0.846
Non-compacted to compacted mass ratio, % 24.8 ± 4.2 26.8 ± 4.0 0.197
Non-compacted volume, % of EDV 17.3 ± 3.4 18.0 ± 2.2 0.538
Values are mean ± standard deviation or median (interquartile range).
EDV, end-diastolic volume; LV, left ventricular.
https://doi.org/10.1371/journal.pone.0237228.t006
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between thin intertrabecular recesses from trabecular mass, and small inter-trabecular space is
generally hard to quantify with cardiac imaging [21, 28]. Nevertheless, as we hypothesized, this
inter-trabecular volume may serve as a source for thrombosis formation.
All of our study subjects had visually normal LV shape, morphology and trabeculation, and
normal LV systolic function. In previous studies, isolated LVNC cardiomyopathy has been fre-
quently associated with myocardial fibrosis, present in approximately half of the patients [29,
Fig 2. Increased left ventricular non-compaction may be associated with cryptogenic ischemic stroke in the young.
https://doi.org/10.1371/journal.pone.0237228.g002
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30], and fibrosis has been related to clinical disease severity and systolic dysfunction [29]. Only
one of our patients had local fibrosis, detected by LGE, but otherwise normal LV morphology
with normal volumes and function. Thus, our study subjects did not have LVNC cardiomyop-
athy phenotype. Earlier, it has been speculated whether increased trabeculation in healthy indi-
viduals is a pre-phenotype of underlying cardiovascular disease and adverse outcome.
However, in a large population-based study of asymptomatic individuals followed by 9.5 years
with repeated CMRs, there was no decline in LV function related to excess non-compaction
[31].
According to a recent meta-analysis, CMR detects more readily LVNC changes compared
to echocardiography, but the clinical significance of these changes is unclear [24]. Our finding
suggests that, increased LVNC may be associated with cryptogenic stroke even if systolic func-
tion is normal.
As a major strength, our case-control study was based on prospectively enrolled patients
with thorough baseline characterization for both cases and controls, including structural and
standardized echocardiography protocol [13, 14]. Another strength is that the semi-automatic
assessment of non-compacted LV mass was highly reproducible, probably due to only minor
manual corrections. A limitation of this study is that the number of patients was modest. How-
ever, this was a pilot study with an extensive CMR imaging protocol, which has not been previ-
ously used in the patient population of interest, and we had no ruling hypothesis of the
optimal sample size. This study gives information for future studies on optimal imaging
sequences, use of imaging time, and optimal sample size. Although we matched controls for
age and gender, and indexed parameters for BSA, we had limited possibilities to further adjust
for confounders. Thus, the findings of this study should be verified in a larger patient cohort.
Also, we were not able to define a cut-off value for non-compacted LV mass predisposing for
cryptogenic stroke, as the assessment of global trabecular mass is method-dependent and we
excluded the most basal LV slices for the consistency of measurements. Furthermore, we did
not assess local non-compacted to compacted LV wall thickness ratio, frequently used to
define isolated LVNC in CMR [32], but the global non-compacted LV mass which has shown
high reproducibility in earlier studies [10–12].
Conclusions
We displayed an association between increased LVNC and cryptogenic ischemic stroke in the
young, independent of concomitant RLS and in the absence of cardiomyopathy, suggesting
that trabeculation may be involved in thrombosis formation and embolic events in these
patients.
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